Mirion Q3 revenue $206.8M (+8.2% YoY); updates FY guidance, narrows FCF range to $65-75M

Mirion Technologies, Inc.

2024-Q3 EPS reported -$0.25 revenue$606,500,000

Q3 revenue $206.8M (+8.2% YoY); GAAP net loss $14.0M ($0.07 loss per share); adjusted EPS $0.08 vs $0.05 YoY.
Adjusted EBITDA $45.7M (+17.8% YoY); margin expanded to 22.1% from 20.3%, fifth consecutive quarter of expansion.
Full-year revenue growth guided 6-7% (organic 5-6%); adjusted EBITDA $195-205M unchanged; adjusted FCF narrowed to $65-75M.
CEO cites strong nuclear and cancer care trends; hyperscaler deals position for future growth; Medical organic growth lowered to LSD.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.